Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles

The use of doxorubicin (DOX), one of the most effective antitumor molecules in the treatment of metastatic breast cancer, is limited by its low tumor selectivity and its severe side effects. Colloidal carriers based on biodegradable poly(butylcyanoacrylate) nanoparticles (PBCA NPs) may enhance DOX a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabeza, Laura, Ortiz, Raúl, Arias, José L, Prados, Jose, Ruiz Martínez, Maria Adolfina, Entrena, José M, Luque, Raquel, Melguizo, Consolación
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335619/
https://www.ncbi.nlm.nih.gov/pubmed/25709449
http://dx.doi.org/10.2147/IJN.S74378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335619/
https://www.ncbi.nlm.nih.gov/pubmed/25709449
http://dx.doi.org/10.2147/IJN.S74378

Ejemplares similares